TY - JOUR
T1 - Differential effects of glucose-dependent insulinotropic polypeptide receptor/glucagon-like peptide-1 receptor heteromerization on cell signaling when expressed in HEK-293 cells
AU - Al-Zaid, Bashaier
AU - Chacko, Siby
AU - Ezeamuzie, Charles Ifeamalume
AU - Bünemann, Moritz
AU - Krasel, Cornelius
AU - Karimian, Tina
AU - Lanzerstorfer, Peter
AU - Al-Sabah, Suleiman
N1 - Funding Information:
This work was supported by Kuwait University, College of Graduate studies. Plasmids containing NES‐Venus‐mG and NES‐Venus‐mG were a kind gift from Dr. Mohammed Ayoub, United Arab Emirates University, Al‐Ain, UAE. P.L. acknowledges funding from the province of Upper Austria as part of the FH Upper Austria Center of Excellence for Technological Innovation in Medicine (TIMed CENTER). s q
Publisher Copyright:
© 2022 The Authors. Pharmacology Research & Perspectives published by British Pharmacological Society and American Society for Pharmacology and Experimental Therapeutics and John Wiley & Sons Ltd.
PY - 2022/10
Y1 - 2022/10
N2 - The incretin hormones: glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) are important regulators of many aspects of metabolism including insulin secretion. Their receptors (GIPR and GLP-1R) are closely related members of the secretin class of G-protein-coupled receptors. As both receptors are expressed on pancreatic β-cells there is at least the hypothetical possibility that they may form heteromers. In the present study, we investigated GIPR/GLP-1R heteromerization and the impact of GIPR on GLP-1R-mediated signaling and vice versa in HEK-293 cells. Real-time fluorescence resonance energy transfer (FRET) and bioluminescence resonance energy transfer (BRET) saturation experiments confirm that GLP-1R and GIPR form heteromers. Stimulation with 1 μM GLP-1 caused an increase in both FRET and BRET ratio, whereas stimulation with 1 μM GIP caused a decrease. The only other ligand tested to cause a significant change in BRET signal was the GLP-1 metabolite, GLP-1 (9-36). GIPR expression had no significant effect on mini-G
s recruitment to GLP-1R but significantly inhibited GLP-1 stimulated mini-G
q and arrestin recruitment. In contrast, the presence of GLP-1R improved GIP stimulated mini-G
s and mini-G
q recruitment to GIPR. These data support the hypothesis that GIPR and GLP-1R form heteromers with differential consequences on cell signaling.
AB - The incretin hormones: glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) are important regulators of many aspects of metabolism including insulin secretion. Their receptors (GIPR and GLP-1R) are closely related members of the secretin class of G-protein-coupled receptors. As both receptors are expressed on pancreatic β-cells there is at least the hypothetical possibility that they may form heteromers. In the present study, we investigated GIPR/GLP-1R heteromerization and the impact of GIPR on GLP-1R-mediated signaling and vice versa in HEK-293 cells. Real-time fluorescence resonance energy transfer (FRET) and bioluminescence resonance energy transfer (BRET) saturation experiments confirm that GLP-1R and GIPR form heteromers. Stimulation with 1 μM GLP-1 caused an increase in both FRET and BRET ratio, whereas stimulation with 1 μM GIP caused a decrease. The only other ligand tested to cause a significant change in BRET signal was the GLP-1 metabolite, GLP-1 (9-36). GIPR expression had no significant effect on mini-G
s recruitment to GLP-1R but significantly inhibited GLP-1 stimulated mini-G
q and arrestin recruitment. In contrast, the presence of GLP-1R improved GIP stimulated mini-G
s and mini-G
q recruitment to GIPR. These data support the hypothesis that GIPR and GLP-1R form heteromers with differential consequences on cell signaling.
KW - Arrestins/metabolism
KW - Gastric Inhibitory Polypeptide/metabolism
KW - Glucagon-Like Peptide 1/metabolism
KW - Glucagon-Like Peptide-1 Receptor/genetics
KW - Glucose/pharmacology
KW - HEK293 Cells
KW - Humans
KW - Incretins
KW - Ligands
KW - Peptides
KW - Receptors, G-Protein-Coupled/metabolism
KW - Receptors, Gastrointestinal Hormone
KW - Secretin/metabolism
KW - Signal Transduction
KW - BRET
KW - GLP-1
KW - G-protein-coupled receptor
KW - heteromerization
KW - GIP
KW - FRET
KW - Glucagon-Like Peptide-1 Receptor/metabolism
KW - Receptors, Gastrointestinal Hormone/metabolism
UR - http://www.scopus.com/inward/record.url?scp=85138942001&partnerID=8YFLogxK
U2 - 10.1002/prp2.1013
DO - 10.1002/prp2.1013
M3 - Article
C2 - 36177761
SN - 2052-1707
VL - 10
JO - Pharmacology Research and Perspectives
JF - Pharmacology Research and Perspectives
IS - 5
M1 - e01013
ER -